Nature’s Toolbox Expands in Rio Rancho, New Mexico
12/11/2020
According to New Mexico Economic Development Department, NTx is working to commercialize its cell-free technology that will expedite the development and manufacturing of vaccines and pharmaceuticals using mRNA and protein technology, now being studied and utilized in the fight against COVID-19.
“We’ve known for a long time that manufacturing of pharmaceuticals, primarily of biologicals, needs to be modernized, vaccines, antibodies, insulin, and hormone and enzyme replacement therapies, it’s a massive effort and a long timeline,” NTx co-founder and president Alex Koglin said. “We truly believe we can provide the technology to replace their manufacturing.”
The city of Rio Rancho is the fiscal agent for the project at 7701 Innovation Way and is also supporting the expansion with up to $500,000 in local LEDA. The Local Economic Development Act award will be paid out in phases as NTx reaches economic development benchmarks as specified in the Project Participation Agreement.
The New Mexico Economic Development Department pledged $1.75 million to NTx when the company occupies and builds out a 25,000-square-foot office and manufacturing center at the Enchanted Hills Commerce Center. Another $3.25 million would be awarded to support future job growth and expansion of the facility's footprint to handle high-volume manufacturing and emergency response. The startup has outgrown its current space in Santa Fe and is on track to relocate and expand its workforce in early 2021.
“NTx is a company that launched in New Mexico and is now expanding in the state and adding high-paying jobs with assistance from LEDA,” Secretary Alicia Keyes said. “New Mexico has proven to be a recognized location for excellence in biosciences. The state investment in NTx will help build new partnerships in this industry and advance these innovative technologies."
NTx, an early stage biomanufacturing and bioinformatics company, has developed a proprietary host-independent biological manufacturing and development platform used for pharmaceutical drug discovery and manufacturing of biologicals to counter disease. The company's vision is to provide materials for a diverse product portfolio, to deliver solutions for difficult-to-make biologics, and to generate drug leads for clinical development, which counter infectious diseases and other health conditions that present a challenge to public health.
"NTx has developed revolutionary technology that will speed up the production, manufacturing and distribution of high quality vaccines and increase access to critical medicine across the globe," added Fred Shepherd, president and CEO of the Sandoval Economic Alliance. "They are a great example of the type of company that can grow and prosper in our community as we strive to become a leader in the bioscience industry. We look forward to continuing to work with them as they grow and expand in our community.”
Project Announcements
Little Leaf Farms Plans Coffee County, Tennessee, Production Operations
07/02/2025
White Rock Truss & Components Expands Lee County, Virginia, Operations
07/02/2025
Fox Tank Company Plans Coshocton, Ohio, Operations
07/02/2025
Ascentek Expands Shreveport, Louisiana, Operations
07/02/2025
ProBio Establishes Hopewell, New Jersey, Gene Therapy Operations
07/02/2025
22nd Century Technologies Expands Fairfax County, Virginia, Headquarters Operations
07/02/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024